Logos Global Management as of March 31, 2022
Portfolio Holdings for Logos Global Management
Logos Global Management holds 47 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cytokinetics Com New (CYTK) | 7.7 | $59M | 1.6M | 36.81 | |
| Alx Oncology Hldgs (ALXO) | 6.6 | $51M | 3.0M | 16.90 | |
| Apellis Pharmaceuticals (APLS) | 5.9 | $46M | 900k | 50.81 | |
| Design Therapeutics (DSGN) | 5.9 | $45M | 2.8M | 16.15 | |
| Neurocrine Biosciences (NBIX) | 5.8 | $45M | 475k | 93.75 | |
| Global Blood Therapeutics In | 5.6 | $43M | 1.3M | 34.64 | |
| Karuna Therapeutics Ord | 5.6 | $43M | 340k | 126.79 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 5.4 | $42M | 950k | 43.88 | |
| Ventyx Biosciences (VTYX) | 4.4 | $34M | 2.5M | 13.57 | |
| Ideaya Biosciences (IDYA) | 4.1 | $32M | 2.9M | 11.19 | |
| Iveric Bio | 3.9 | $30M | 1.8M | 16.83 | |
| Arcutis Biotherapeutics (ARQT) | 3.7 | $29M | 1.5M | 19.26 | |
| Mirati Therapeutics | 3.7 | $29M | 350k | 82.22 | |
| Kezar Life Sciences (KZR) | 3.5 | $27M | 1.6M | 16.62 | |
| Dice Therapeutics | 3.4 | $27M | 1.4M | 19.13 | |
| Dyne Therapeutics (DYN) | 3.4 | $26M | 2.7M | 9.64 | |
| Fulcrum Therapeutics (FULC) | 3.1 | $24M | 1.0M | 23.65 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.7 | $21M | 175k | 117.36 | |
| Iovance Biotherapeutics (IOVA) | 2.2 | $17M | 1.0M | 16.65 | |
| Olema Pharmaceuticals (OLMA) | 2.1 | $16M | 3.7M | 4.26 | |
| Athira Pharma (ATHA) | 1.3 | $9.7M | 717k | 13.50 | |
| Jounce Therapeutics | 1.2 | $9.5M | 1.4M | 6.79 | |
| Vera Therapeutics Cl A (VERA) | 1.2 | $9.0M | 385k | 23.49 | |
| Scholar Rock Hldg Corp (SRRK) | 1.1 | $8.7M | 675k | 12.89 | |
| Anaptysbio Inc Common (ANAB) | 1.0 | $7.4M | 300k | 24.74 | |
| Century Therapeutics (IPSC) | 0.9 | $6.9M | 550k | 12.59 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $4.1M | 455k | 8.97 | |
| Instil Bio | 0.5 | $4.1M | 377k | 10.75 | |
| Talaris Therapeutics | 0.4 | $3.0M | 306k | 9.84 | |
| Tyra Biosciences (TYRA) | 0.4 | $2.7M | 253k | 10.70 | |
| Verve Therapeutics (VERV) | 0.3 | $2.2M | 97k | 22.82 | |
| Cullinan Oncology (CGEM) | 0.3 | $2.1M | 200k | 10.47 | |
| Edgewise Therapeutics (EWTX) | 0.3 | $2.1M | 214k | 9.70 | |
| Spruce Biosciences (SPRB) | 0.3 | $2.0M | 1.0M | 2.01 | |
| Nuvalent Inc-a (NUVL) | 0.2 | $1.9M | 135k | 13.89 | |
| Lianbio Sponsored Ads (LIANY) | 0.2 | $1.5M | 413k | 3.71 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.2 | $1.5M | 300k | 4.99 | |
| Vigil Neuroscience (VIGL) | 0.2 | $1.4M | 206k | 7.03 | |
| Vistagen Therapeutics Com New | 0.2 | $1.2M | 1.0M | 1.24 | |
| Pyxis Oncology Common Stock (PYXS) | 0.2 | $1.2M | 287k | 4.04 | |
| Cogent Biosciences (COGT) | 0.1 | $1.1M | 150k | 7.49 | |
| Ikena Oncology (IKNA) | 0.1 | $1.1M | 178k | 6.10 | |
| Biomea Fusion (BMEA) | 0.1 | $892k | 200k | 4.46 | |
| Somalogic Class A Com | 0.1 | $802k | 100k | 8.02 | |
| Rain Therapeutics | 0.1 | $680k | 134k | 5.07 | |
| Omega Therapeutics Common Stock (OMGA) | 0.0 | $81k | 13k | 6.24 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $54k | 67k | 0.81 |
